Approaches to treatment of type 2 diabetes

被引：13
作者：
Bloomgarden, Zachary T. [1 ]
机构：
[1] Mt Sinai Sch Med, Div Endocrinol, New York, NY USA
来源：
DIABETES CARE | 2008年 / 31卷 / 08期
关键词：
D O I：
10.2337/dc08-zb08
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1697 / 1703
页数：7
相关论文
共 50 条
  • [1] Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
    Aschner, Pablo
    Kipnes, Mark S.
    Lunceford, Jared K.
    Sanchez, Matilde
    Mickel, Carolyn
    Williams-Herman, Debora E.
    [J]. DIABETES CARE, 2006, 29 (12) : 2632 - 2637
  • [2] Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach
    Bays, H
    Mandarino, L
    DeFronzo, RA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) : 463 - 478
  • [3] A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
    Belfort, Renata
    Harrison, Stephen A.
    Brown, Kenneth
    Darland, Celia
    Finch, Joan
    Hardies, Jean
    Balas, Bogdan
    Gastaldelli, Amalia
    Tio, Fermin
    Pulcini, Joseph
    Berria, Rachele
    Ma, Jennie Z.
    Dwivedi, Sunil
    Havranek, Russell
    Fincke, Chris
    DeFronzo, Ralph
    Bannayan, George A.
    Schenker, Steven
    Cusi, Kenneth
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) : 2297 - 2307
  • [4] The proposed terminology 'A1c-derived average glucose' is inherently imprecise and should not be adopted
    Bloomgarden, Z. T.
    Inzucchi, S. E.
    Karnieli, E.
    Le Roith, D.
    [J]. DIABETOLOGIA, 2008, 51 (07) : 1111 - 1114
  • [5] Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy - A meta-regression analysis
    Bloomgarden, Zachary T.
    Dodis, Regina
    Viscoli, Catherine M.
    Holmboe, Eric S.
    Inzucchi, Silvio E.
    [J]. DIABETES CARE, 2006, 29 (09) : 2137 - 2139
  • [6] Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus
    Bolen, Shari
    Feldman, Leonard
    Vassy, Jason
    Wilson, Lisa
    Yeh, Hsin-Chieh
    Marinopoulos, Spyriclon
    Wiley, Crystal
    Selvin, Elizabeth
    Wilson, Renee
    Bass, Eric B.
    Brancati, Frederick L.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 147 (06) : 386 - 399
  • [7] The burden of treatment failure in type 2 diabetes
    Brown, JB
    Nichols, GA
    Perry, A
    [J]. DIABETES CARE, 2004, 27 (07) : 1535 - 1540
  • [8] Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women
    Buchanan, TA
    Xiang, AH
    Peters, RK
    Kjos, SL
    Marroquin, A
    Goico, J
    Ochoa, C
    Tan, S
    Berkowitz, K
    Hodis, HN
    Azen, SP
    [J]. DIABETES, 2002, 51 (09) : 2796 - 2803
  • [9] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    Charbonnel, Bernard
    Karasik, Avraham
    Liu, Ji
    Wu, Mei
    Meininger, Gary
    [J]. DIABETES CARE, 2006, 29 (12) : 2638 - 2643
  • [10] Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death
    Diamond, George A.
    Bax, Leon
    Kaul, Sanjay
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 147 (08) : 578 - 581
12345